MASTER first year programme
OVERVIEW
The Master year 1 programme is half-composed of theoretical training (course modules) and practical training (research project).
Each part shall be successfully completed to be granted rights to pursue the second year programme of the Master in Pharmacovigilance and Pharmacoepidemiology.
| Year workload | 60 ECTS credits |
|---|---|
| Pace | Full time or part-time |
| Training mode | Blended learning research project + e-learning |
| Language | English |
| Degree | Master of Science after second year completion (120 ECTS credits) |
THEORETICAL TRAINING
| Module | Workload in ECTS credits |
|---|---|
| Total theoretical curriculum | 30 Ects |
|
Basics in epidemiology
To understand the basic concepts and principles in epidemiology To become familiar with the epidemiological tools that could be used in pharmacovigilance and pharmacoepidemiology To understand the specificity of epidemiological tools applied to pharmacovigilance and pharmacoepidemiology Health indices, observational studies, cohort, case-control, causality, bias, drug safety MORE DETAILS ABOUT THE MODULE |
3 Ects |
|
Basics in statistics
To understand applications of probability in statistics To understand how to organize and describe epidemiological data To understand how to perform data estimations, comparisons and predictions To understand how to estimate the sample size and power of epidemiology studies To introduce the principles of multivariable comparisons Probability, descriptive statistics, statistical tests, confidence interval, regression, drug safety MORE DETAILS ABOUT THE MODULE |
3 Ects |
|
Valorisation and critical appraisal in research
To become familiar with the different tools that could be used in pharmacovigilance and pharmacoepidemiology research implementation To become familiar with the principles of scientific communication Critical reading, Scientific writing, Scientific communication, Scientific watch, Health institutions, Funding MORE DETAILS ABOUT THE MODULE |
6 Ects |
|
Basics in clinical pharmacology
To understand the role of medicines in therapeutics, health services and society To become familiar with the life cycle of medicines and the regulatory aspects of medicines market To review the clinical and pharmacological basis of prescribing To understand the need to evaluate the effects of medicines from an epidemiological perspective To understand the relevance of unbiased information to ensure the appropriate use of medicines To discuss the need to monitor medicines prescribing process Clinical pharmacology, epidemiology, clinical trials, efficacy, effectiveness, medicines prescribing, regulation of medicines development and market MORE DETAILS ABOUT THE MODULE |
3 Ects |
|
Principles of pharmacovigilance
To enable trainees to develop an understanding of the principles of pharmacovigilance from the development of the science to its place in pre and post-marketing environment and the roles of various stakeholders within pharmacovigilance. Introduction, regulations, legislation, principles MORE DETAILS ABOUT THE MODULE |
3 Ects |
|
Basics in pharmacoepidemiology
To understand how to evaluate the effects of medicines and therapeutic interventions both during drug development and clinical use To know the main methodological and ethical characteristics and limitations of randomized clinical trials To understand the differences between efficacy and effectiveness To know the basic concepts and classification of the pharmacoepidemiological studies designed to evaluate therapeutic interventions To identify information gaps in selected therapeutic areas (e.g. cardiovascular, psychiatry, diabetes care) Pharmacoepidemiology, efficacy, effectiveness, benefit-risk, observational studies, experimental studies, clinical settings, population MORE DETAILS ABOUT THE MODULE |
3 Ects |
|
Basics in communication
To know the basic principles of communication and to gain an insight into the characteristics of effective communication To face to the complexity communication on risk for health To know the evolution of medicine risk communication Communication, basic principles of risk communication on medicines MORE DETAILS ABOUT THE MODULE |
3 Ects |
| Tutored project This tutored project aims at evaluating the ability of a trainee to work in collaboration with one or several other trainees to design and conceptualize a research project according to the Eu2P tutor instructions within a set deadline. |
6 Ects |
Evaluation
Each module evaluation may be evaluated through continuous and final assessment. First year trainees obtaining a pass grade in each module validate the theoretical training part of the first year Master programme.
This theoretical training evaluation counts for half of the first year programme grade.
PRACTICAL TRAINING
Each Master trainee must conduct a research project in parallel to the theoretical training along the academic year. This research project can be achieved within an academic, regulatory or private body (see Master Programme FAQ for further details).
Note: If you are employed, you can do the research project on your employer's premises.
Evaluation
This research project is assessed through three separates assessments: 1) the research project supervisor evaluation, 2) the project written report, and 3) the oral defence of the research project report.
This practical training evaluation counts for half of the first year programme grade.
REGISTRATION
PROFILE & PREREQUISITES
The Master year 1 targets students and professionals with a Bachelor or an equivalence(*) in Health or Life sciences.
(*): see SELECTION BOARD section down this page.
To be eligible, you must:
- be fluent in English (English taught training)
- be familiar with computer use and have Internet access
KEY DATES & COURSE CALENDAR
| Application | From January 28th, 2013 to June 23rd, 2013 |
|---|---|
| Selection | July 08th, 2013 |
| Registration | From July 15th, 2013 to September 16th, 2013 |
| Programme | From September 24th, 2013 to July 11th, 2014 |
| 2013 | 2014 | ||||||||||||||||||||||||||
| Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | |||||||||||||||||
| 01 | 01 | 01 | 01 | 01 | 01 | 01 | 01 | 01 | 01 | 01 | |||||||||||||||||
| 02 | 02 | 02 | 02 | 02 | 02 | 02 | 02 | 02 | 02 | 02 | |||||||||||||||||
| 03 | 03 | 03 | 03 | 03 | 03 | 03 | 03 | 03 | 03 | 03 | |||||||||||||||||
| 04 | 04 | 04 | 04 | 04 | 04 | 04 | 04 | 04 | 04 | 04 | |||||||||||||||||
| 05 | 05 | 05 | 05 | 05 | 05 | 05 | 05 | 05 | 05 | 05 | |||||||||||||||||
| 06 | 06 | 06 | 06 | 06 | 06 | 06 | 06 | 06 | 06 | 06 | |||||||||||||||||
| 07 | 07 | 07 | 07 | 07 | 07 | 07 | 07 | 07 | 07 | 07 | |||||||||||||||||
| 08 | 08 | 08 | 08 | 08 | 08 | 08 | 08 | 08 | 08 | 08 | |||||||||||||||||
| 09 | 09 | 09 | 09 | 09 | 09 | 09 | 09 | 09 | 09 | 09 | |||||||||||||||||
| 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||||||||||||||
| 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | |||||||||||||||||
| 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||||||||||||
| 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | |||||||||||||||||
| 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||||||||||||||
| 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | |||||||||||||||||
| 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | |||||||||||||||||
| 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | |||||||||||||||||
| 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | |||||||||||||||||
| 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | |||||||||||||||||
| 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||||||||||||||
| 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | |||||||||||||||||
| 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |||||||||||||||||
| 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | |||||||||||||||||
| 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | |||||||||||||||||
| 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||||||||||||||
| 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | |||||||||||||||||
| 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | |||||||||||||||||
| 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | |||||||||||||||||
| 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | ||||||||||||||||||
| 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | ||||||||||||||||||
| 31 | 31 | 31 | 31 | 31 | 31 | ||||||||||||||||||||||
Fresher's week session (face-to-face)
Online course period
Schedule for online meeting sessions, excercice deadline, and resource availability will be provided by the trainers' team
Assessment period
Details on the exam organisation are provided by the trainers' team
The research project period
The research project defense and award
FEES & SAVINGS
Application fees
The Master application fees amount is 25.00 Euros.
Those fees can be paid either by on-line payment or by post before the application deadline.
Those fees are not refundable.
Tuition fees
| Students | Professionals |
|---|---|
| 7,000 Euros | 12,000 Euros |
Grant
Eu2P enables grant application for Master students.
Attributions of grant is based on merit and reasearch interest grounds.
See Eu2P grant for further details.
Savings
Students and professionals related to Eu2P partners can claim some saving on Master tuition fees.
See Eu2P savings for further details.
SELECTION BOARD
The Education Board selects the Master trainees.
This board assesses applicants's previous education, work and research experience, prerequisites' compliance, statement of motivation, and specific request such as part-time completion.
See Eu2P academic governance for further details about the Eu2P Educational Board.
CONTACT INFORMATION
You can contact the Eu2P central office to get further information about:
- Candidate application, selection and enrolment
- Tuition fees, grants and savings
- Course calendar
- Research project placements and mobility
- Exams organisation
Send an online message to the Eu2P central office
